Paclitaxel Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of paclitaxel that may be used in the treatment of anaplastic thyroid carcinomas, thymomas and thymic carcinomas; soft tissue and Kaposi sarcomas; bladder, cervical, esophageal and esophagogastric junction, gastric, head and neck, endometrial, penile, ovarian, fallopian tube, primary peritoneal, vaginal, and vulvar cancers; small cell and non-small cell lung cancers; small bowel adenocarcinoma; cutaneous and uveal melanoma; salivary gland tumor, and malignant sex cord-stromal and malignant germ cell tumors. Paclitaxel every 21 days regimen may be used for the treatment of breast, ovarian, fallopian tube, and primary peritoneal cancers. Paclitaxel every 14 days regimen may be used for the treatment of breast cancer.

**Synonyms:** - Paclitaxel monotherapy - Taxol Regimen